HSPA1A is upregulated in CD4+ and CD8+ T cells after treatment with immune checkpoint blockers in various cancers, such as renal cancer, lung cancer, and basal cell carcinoma [20]. This evidence concerns the gene HSPA1A and basal cell carcinoma.